Optune Lua received a CE Mark for metastatic non–small cell lung cancer with immune checkpoint inhibitors or docetaxel.

A push for answers led to a rare blood disorder diagnosis after Joy’s symptoms were initially dismissed.

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

The FDA granted breakthrough therapy designation to an autologous CAR-T cell therapy for pediatric patients with diffuse ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

As spring arrives, I embrace the season’s renewal, reflecting on my journey with cancer and the freedom I’ll feel when I stop ...

An expert sat down to discuss the emotional and physical barriers patients may face when seeking support for fear of cancer ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

The first patient with relapsed or refractory CD5-positive T-cell lymphoma has been dosed with the CAR-T cell therapy MB-105.

It’s spring, a time for new beginnings following a cancer diagnosis; however, I have an ongoing issue that I can’t dismiss.

Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian ...

Dr. Matthew Galsky discusses the FDA approval of Imfinzi and chemo before and after surgery for muscle-invasive bladder ...